GlassScriptPhysician profile
Michelle Choy
NPI 1780237073
$4,375.23
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $595 · 2021: $1,626 · 2022: $1,593 · 2023: $143 · 2024: $419.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $561.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $561.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,432.97 | 2020-2021 | |
| Bausch & Lomb Americas INC. | $932.73 | 2022-2024 | Xiidra, Miebo |
| Eyevance Pharmaceuticals LLC | $545.51 | 2021 | |
| Allergan, INC. | $374.32 | 2022 | |
| Glaukos Corporation | $274.89 | 2024 | Ce-Marked Kxla System |
| Alcon Vision LLC | $265.06 | 2022-2023 | Total30, Precision 1, Dailies Total1 |
| Johnson & Johnson Vision Care, INC. | $183.93 | 2022 | |
| Novartis Pharmaceuticals Corporation | $124.45 | 2020 | |
| Oyster Point Pharma, INC. | $123.06 | 2022 | |
| Sun Pharmaceutical Industries INC. | $118.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Choy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.